Clinical Trials Directory

Trials / Unknown

UnknownNCT04064281

The Healthy Cantonese Diet on Cardiometabolic Syndrome

Effect of the Healthy Cantonese Diet on Cardiometabolic Syndrome in Chinese Adults

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The DASH diet (Dietary Approaches to Stop Hypertension) have been proven to lower risk of cardiovascular diseases. But the DASH diet is inconsistent with Chinese dietary pattern. In this study, based on the typical Cantonese diet, the healthy Cantonese diet is developed according to the DASH diet and the balanced dietary pattern of the Chinese Dietary Guidelines 2016. The randomized control trial is designed to investigate whether the healthy Cantonese diet has benefit to blood pressure, blood lipid, blood glucose and other cardiometabolic biomarkers among adults with cardiometabolic syndrome in Guangdong, China.

Conditions

Interventions

TypeNameDescription
OTHERthe healthy Cantonese dietAfter a 1-week run-in period, the intervention group will eat the healthy Cantonese diet for 4 consecutive weeks. Free meals will be provided 3 times a day (breakfast, lunch, dinner). The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake. All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.
OTHERthe typical Cantonese dietAfter a 1-week run-in period, the control group will still eat the typical Cantonese diet for 4 consecutive weeks. Free meals will be provided 3 times a day (breakfast, lunch, dinner). The actually intake of every meal for all subjects will be recorded to estimate their nutrients intake. All subjects will be advised to avoid eating other food, but they should inform researchers of what they eat if they eat food that we will not provide.

Timeline

Start date
2019-09-01
Primary completion
2021-12-31
Completion
2022-12-31
First posted
2019-08-21
Last updated
2019-08-21

Source: ClinicalTrials.gov record NCT04064281. Inclusion in this directory is not an endorsement.